NOBIVAC DHPPI Írland - enska - HPRA (Health Products Regulatory Authority)

nobivac dhppi

intervet ireland limited - canine distemper virus strain ondertespoort (live), canine adenovirus type 2 strain manhattan lpv3 (live), canine parvovirus strain 154 (live), canine parainfluenza virus strain cornell live - lyophilisate for reconstitution for injection - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine + canine para - canine - immunological - live vaccine

Ixiaro Evrópusambandið - enska - EMA (European Medicines Agency)

ixiaro

valneva austria gmbh - japanese-encephalitis virus, inactivated (attenuated strain sa14-14-2 grown in vero cells) - encephalitis, japanese; immunization - vaccines - ixiaro is indicated for active immunisation against japanese encephalitis in adults, adolescents, children and infants aged two months and older.ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.

Nobivac DHPPi Írland - enska - HPRA (Health Products Regulatory Authority)

nobivac dhppi

intervet ireland limited - canine distemper virus strain ondertespoort (live); canine adenovirus type 2 strain manhattan lpv3 (live); canine parvovirus strain 154 (live); canine parainfluenza virus strain cornell (live) - lyophilisate for solution for injection - . - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dogs - immunological - live vaccine

NABI-HB- human hepatitis b virus immune globulin injection Bandaríkin - enska - NLM (National Library of Medicine)

nabi-hb- human hepatitis b virus immune globulin injection

adma biologics, inc - human hepatitis b virus immune globulin (unii: xii270yc6m) (human hepatitis b virus immune globulin - unii:xii270yc6m) - human hepatitis b virus immune globulin 1560 [iu] in 5 ml - indications and usage nabi-hb, hepatitis b immune globulin (human), is indicated for treatment of acute exposure to blood containing hbsag, perinatal exposure of infants born to hbsag-positive mothers, sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick, bite, sharps), direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident), involving hbsag-positive materials such as blood, plasma, or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag12. sexual exposure to hbsag-positive persons sexual partners of hbsag-positive persons. household exposure to persons with acute hbv infection infants less than 12 months old whose mother or primary caregiver is positive for hbsag. other household contacts with an identifiable blood exposure to the i

NABI-HB- human hepatitis b virus immune globulin injection Bandaríkin - enska - NLM (National Library of Medicine)

nabi-hb- human hepatitis b virus immune globulin injection

adma biologics, inc - human hepatitis b virus immune globulin (unii: xii270yc6m) (human hepatitis b virus immune globulin - unii:xii270yc6m) - human hepatitis b virus immune globulin 312 [iu] in 1 ml - indications and usage nabi-hb, hepatitis b immune globulin (human), is indicated for treatment of acute exposure to blood containing hbsag, perinatal exposure of infants born to hbsag-positive mothers, sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick, bite, sharps), direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident), involving hbsag-positive materials such as blood, plasma, or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag12. sexual exposure to hbsag-positive persons sexual partners of hbsag-positive persons. household exposure to persons with acute hbv infection infants less than 12 months old whose mother or primary caregiver is positive for hbsag. other household contacts with an identifiable blood exposure to the i

Nobivac Rabies Formulation:   Each 1 mL (dose) contains:   Rabies Virus (Pasteur RIV Strain).............. > 2I.U. IU-International Units Suspension for Injection (SC/IM) Filippseyjar - enska - FDA (Food And Drug Administration)

nobivac rabies formulation: each 1 ml (dose) contains: rabies virus (pasteur riv strain).............. > 2i.u. iu-international units suspension for injection (sc/im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated rabies virus vaccine (vet.) - suspension for injection (sc/im) - formulation: each 1 ml (dose) contains: rabies virus (pasteur riv strain).............. > 2i.u. iu-international units

KAMRAB rabies immunoglobulin 150 IU/mL solution for injection vial Ástralía - enska - Department of Health (Therapeutic Goods Administration)

kamrab rabies immunoglobulin 150 iu/ml solution for injection vial

link medical products pty ltd t/a link pharmaceuticals - rabies immunoglobulin, quantity: 150 iu/ml - injection, solution - excipient ingredients: sodium hydroxide; glycine; water for injections - kamrab is rabies immunoglobulin indicated for passive, transient post-exposure prophylaxis (pep) of rabies infection, when given immediately after contact with a rabid or possibly rabid animal.,kamrab should be administered concurrently with a full course of rabies vaccine.,? do not administer additional (repeat) doses of kamrab once vaccine treatment has been initiated, since this may interfere with the immune response to the rabies vaccine.,? do not administer kamrab to patients with a history of a complete pre-exposure or post-exposure vaccination regimen and confirmed adequate rabies antibody titre.

Verorab rabies virus vaccine (inactivated) 3.25 IU powder for injection vial with diluent pre-filled syringe with attached needle Ástralía - enska - Department of Health (Therapeutic Goods Administration)

verorab rabies virus vaccine (inactivated) 3.25 iu powder for injection vial with diluent pre-filled syringe with attached needle

sanofi-aventis australia pty ltd - rabies virus, quantity: 3.25 iu - diluent, not applicable - excipient ingredients: water for injections; sodium chloride - verorab is indicated for pre-exposure prophylaxis against rabies. verorab is indicated for post-exposure prophylaxis against rabies. verorab should be used in accordance with official local recommendations.

Rabitec Evrópusambandið - enska - EMA (European Medicines Agency)

rabitec

ceva santé animale - attenuated live rabies vaccine virus, strain spbn gasgas - immunologicals for canidae, live viral vaccines - red foxes (vulpes vulpes); raccoon dogs (nyctereutes procyonoides) - for the active immunisation of foxes and raccoon dogs against rabies to prevent infection and mortality.